- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03519139
Individual Nutritional Intervention for the Prevention of Readmission Among Geriatric Patients
Individual Nutritional Intervention for the Prevention of Readmission Among Geriatric Patients - a Randomized Clinical Study
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Method/Design:
The trial is conducted as a randomized clinical trial, with recruitment of 40 medical geriatric patients (definition: ≥65 years of age with at least two diagnoses, e.g. hypertension, cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, rheumatic diseases or apoplexy). At discharge the test subjects are randomized to receive either individual dietary counseling or standard treatment with follow-up 30 and 60 days after discharge. All data are collected prior to randomization. The intervention consists of three individual dietary counsellings with the aim to ensure sufficient coverage of energy and protein needs of the subjects (the first at the hospital by discharge, then in week 1 and week 3 at the subject's home/the respite care after discharge) and, if necessary, telephone follow-up in weeks 2 and 4 after discharge. The intervention group, if possible, are asked to take photos of all they eat and drink for two days before individual dietary counselling and send the photos electronically to the responsible investigators before the meeting.
Recruitment:
Only admitted patients are included in the trial. Attending physician finds the patients through the Health Platform at Sydsjællands University Hospital. The care staff or the attending physician asks whether the patient is willing to talk with the responsible investigators. The responsible investigators then make personal contact with the geriatric patients while they are hospitalized. Patients will be informed orally and in writing about the trial of the responsible investigators. Patients also receive pamphlets about test subjects rights in a health science research project published by the National Science Ethics Committee with the purpose of giving patients an informed basis to make a decision.
Patients are informed that they can take a family member or friend to the next conversation. Patients receive at least 24 hours of deliberation time, after which they are contacted by the responsible investigators. Patients who wish to participate in the trial are asked to sign a consent statement. This statement is also signed by the responsible investigator who has given the patient oral information about the trial. The subjects are offered a copy of the consent statement. To ensure uninterrupted conversation, conversation will take place in a room without other people or alternatively in the patient's room and a partition will be put of if the patient is not in a room by them self.
Patients who meet the inclusion criteria, wishes to participate in the trial and have signed the consent statement will be contacted again on the date of discharge or the day before, where the trial starts. Test subject may at any time, orally, in writing or by other clear indication, withdraw their consent for participation and withdraw from the trial.
Sample size:
Based on the primary output "readmission/hospitalization of geriatric patients within a month", the sample size is estimated to be at least 20 subjects in the intervention and control groups, respectively. A total of at least 40 subjects.
Statistical analysis:
Hypothesis testing will take place using nonparametric statistical tests, as the data can not be assumed to be normal distribution (Mann-Whitney U and Wilcoxon). Fisher's exact test [M1] is used for analysis of categorical data. Correlations are analyzed using Spermann analysis
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Køge, Denemarken, 4600
- Sjaellands Universitetshospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- recruited at Medical Department at Sjælland University Hospital, Køge (sections M1, M2, M6, L1) and discharged to one of following municipalities: Greve, Køge, Roskilde, Solrød and Stevns
- geriatric patients according to the definition
- competent adult and Danish speaking who are able to give written consent
- oral nutrition possible (no tube feeding or intravenous nutrition)
- discharged planned for home or respite care or similar (e.g. family).
Exclusion Criteria:
- diagnosed dementia or under investigation for dementia
- nursing home resident or discharged to nursing homes
- terminal patients
- patients who desire weight loss
- scheduled readmission.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: individual dietary counselling
three individual dietary counsellings.
The first at the hospital by discharge, then in week 1 and week 3 at the subject's home/the respite care after discharge and, if necessary, telephone follow-up in weeks 2 and 4 after discharge
|
individual dietary counsellings with the aim to ensure sufficient coverage of energy and protein needs of the test subjects
|
Geen tussenkomst: Control
standard counselling provided by the hospital at discharge.
The standard counselling may include nutritional prescription and nutritional plan, but no follow-up to the nutrition plan after the discharge.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
readmission-or hospitalization rate (%)
Tijdsspanne: 30 days after discharge
|
readmission for the same diagnosis as at discharge.
Hospitalization for a new diagnosis
|
30 days after discharge
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
readmission-/hospitalization rate (%)
Tijdsspanne: 60 days after discharge
|
readmission for the same diagnosis as at discharge.
Hospitalization for a new diagnosis
|
60 days after discharge
|
number of days between readmission or hospitalization and discharge (days)
Tijdsspanne: 30 and 60 days after discharge
|
date minus date
|
30 and 60 days after discharge
|
nutritional status (%)
Tijdsspanne: 30 and 60 days after discharge
|
The proportion of subject who has covered at least 75% of estimated energy and protein needs
|
30 and 60 days after discharge
|
functional status (score, points)
Tijdsspanne: 30 and 60 days after discharge
|
Functional recovery score: P-ADL, I-ADL and mobility
|
30 and 60 days after discharge
|
Quality of Life (score, points)
Tijdsspanne: 30 and 60 days after discharge
|
EQ-5D-5L
|
30 and 60 days after discharge
|
muscle strenght (dyn)
Tijdsspanne: 30 and 60 days after discharge
|
Hand-grip strenght
|
30 and 60 days after discharge
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
mortality (%)
Tijdsspanne: 30 and 60 days after discharge
|
% died from any cause
|
30 and 60 days after discharge
|
side effects in connection with the intervention (number)
Tijdsspanne: 30 and 60 days after discharge
|
any side-effects reported
|
30 and 60 days after discharge
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Jens Rikardt Andersen, ass. prof., University of Copenhagen
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- H-17039329
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- Leerprotocool
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op individual dietary counselling
-
Oregon Health and Science UniversityVoltooidOngerustheid | Impulsiviteit | OnoplettendheidVerenigde Staten
-
Unity Health TorontoCanadian Diabetes AssociationVoltooidCoronaire hartziekte | Diabetes mellitus type IICanada
-
University of VermontVoltooid
-
Emory UniversityCenters for Disease Control and PreventionGeschorstNiertransplantatieVerenigde Staten
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)VoltooidMiddelenmisbruik, intraveneusVerenigde Staten